CODA MINERALS LTD — Director's Dealing 2022

Nov 17, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Coda Minerals Ltd ABN 49 625 763 957

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Christopher Stevens
Date of last notice	14 July 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Dr Catriona Fleur Stevens - spouse
Date of change	17 November 2022
No. of securities held prior to change	Direct Christopher Stevens 358,174 fully paid ordinary shares Indirect Dr Catriona Fleur Stevens – spouse 34,415 fully paid ordinary shares 2,000,000 options, exercise price $0.2145 and expiring on 3 July 2024 68,831 2021 Performance Rights
Class	2022 Performance Rights
Number acquired	471,602 2022 Performance Rights

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil - performance rights issued in accordance with shareholder approval obtained at the AGM held on 9 November 2022.
No. of securities held after change	Direct Christopher Stevens 358,174 fully paid ordinary shares Indirect Dr Catriona Fleur Stevens – spouse 34,415 fully paid ordinary shares 2,000,000 options, exercise price $0.2145 and expiring on 3 July 2024 68,831 2021 Performance Rights 471,602 2022 Performance Rights
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of 471,602 performance rights in accordance with shareholder approval obtained at the AGM held on 9 November 2022.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3